• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马尿酸作为调控草酸钙结石过饱和度的重要物质:生理学证据。

Hippuric acid as a significant regulator of supersaturation in calcium oxalate lithiasis: the physiological evidence.

机构信息

Department of Clinical Laboratory and Clinical Immunology, Medical University, "G. Sofiisky" Boulevard 1, 1431 Sofia, Bulgaria.

出版信息

Biomed Res Int. 2013;2013:374950. doi: 10.1155/2013/374950. Epub 2013 Nov 7.

DOI:10.1155/2013/374950
PMID:24307993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3838840/
Abstract

At present, the clinical significance of existing physicochemical and biological evidence and especially the results we have obtained from our previous in vitro experiments have been analyzed, and we have come to the conclusion that hippuric acid (C6H5CONHCH2COOH) is a very active solvent of Calcium Oxalate (CaOX) in physiological solutions. Two types of experiments have been discussed: clinical laboratory analysis on the urine excretion of hippuric acid (HA) in patients with CaOX lithiasis and detailed measurements of the kinetics of the dissolution of CaOX calculi in artificial urine, containing various concentrations of HA. It turns out that the most probable value of the HA concentration in the control group is approximately ten times higher than the corresponding value in the group of the stone-formers. Our in vitro analytical measurements demonstrate even a possibility to dissolve CaOX stones in human urine, in which increased concentration of HA have been established. A conclusion can be that drowning out HA is a significant regulator of CaOX supersaturation and thus a regulation of CaOX stone formation in human urine. Discussions have arisen to use increased concentration of HA in urine both as a solubilizator of CaOX stones in the urinary tract and on the purpose of a prolonged metaphylactic treatment.

摘要

目前,我们分析了现有物理化学和生物学证据的临床意义,特别是我们以前在体外实验中获得的结果,得出结论:马尿酸(C6H5CONHCH2COOH)是生理溶液中草酸钙(CaOX)非常活跃的溶剂。讨论了两种类型的实验:对草酸钙结石患者尿液中马尿酸(HA)排泄的临床实验室分析,以及对含有各种浓度 HA 的人工尿液中 CaOX 结石溶解动力学的详细测量。事实证明,对照组中 HA 的最可能浓度值大约是结石形成组相应值的十倍。我们的体外分析测量甚至表明有可能在已确定 HA 浓度增加的人尿中溶解 CaOX 结石。可以得出这样的结论:抑制 HA 是调节 CaOX 过饱和度的重要调节剂,从而调节人尿中 CaOX 结石的形成。有人提出,增加尿液中的 HA 浓度,既可以作为尿路中 CaOX 结石的溶解剂,也可以作为长期预防治疗的目的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba35/3838840/3e7c6972400d/BMRI2013-374950.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba35/3838840/4d7f183c130b/BMRI2013-374950.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba35/3838840/3e7c6972400d/BMRI2013-374950.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba35/3838840/4d7f183c130b/BMRI2013-374950.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba35/3838840/3e7c6972400d/BMRI2013-374950.002.jpg

相似文献

1
Hippuric acid as a significant regulator of supersaturation in calcium oxalate lithiasis: the physiological evidence.马尿酸作为调控草酸钙结石过饱和度的重要物质:生理学证据。
Biomed Res Int. 2013;2013:374950. doi: 10.1155/2013/374950. Epub 2013 Nov 7.
2
Hippuric acid as a modifier of calcium oxalate crystallisation.马尿酸作为草酸钙结晶的改性剂。
Clin Chem Lab Med. 2001 Mar;39(3):218-22. doi: 10.1515/CCLM.2001.034.
3
Solubility, inhibited growth and dissolution kinetics of calcium oxalate crystals in solutions, containing hippuric acid.草酸钙晶体在含有马尿酸的溶液中的溶解度、生长抑制及溶解动力学
Urol Res. 1993 May;21(3):181-5. doi: 10.1007/BF00590034.
4
Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.正常人及特发性草酸钙结石患者中过饱和度与草酸钙结晶的关系。
Kidney Int. 1999 Mar;55(3):1041-50. doi: 10.1046/j.1523-1755.1999.0550031041.x.
5
Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.基于即时和24小时尿液样本的草酸钙结石病的尿饱和度及危险因素
Front Biosci. 2003 Sep 1;8:a167-76. doi: 10.2741/1139.
6
Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.“纯”尿酸肾结石患者与“纯”草酸钙结石形成者的临床和生化特征比较。
Urol Res. 2007 Oct;35(5):247-51. doi: 10.1007/s00240-007-0109-1. Epub 2007 Sep 6.
7
Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.饮食中草酸盐增加并不会提高高钙尿症大鼠尿草酸钙饱和度。
Kidney Int. 1999 Feb;55(2):602-12. doi: 10.1046/j.1523-1755.1999.00281.x.
8
Differentiating calcium oxalate and hydroxyapatite stones in vivo using dual-energy CT and urine supersaturation and pH values.应用双能 CT 以及尿液过饱和度和 pH 值值对体内草酸钙和羟磷灰石结石进行鉴别诊断。
Acad Radiol. 2013 Dec;20(12):1521-5. doi: 10.1016/j.acra.2013.08.018.
9
Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.尿大分子对特发性结石形成者和健康对照者草酸钙成核的影响。
Clin Chim Acta. 1995 Jul 31;239(1):1-11. doi: 10.1016/0009-8981(95)06092-r.
10
24-Hour Urine Calcium Oxalate Supersaturation Risk Correlates with Computerized Tomography Volumetric Calcium Oxalate Stone Growth.24 小时尿液钙草酸饱和度与计算机断层扫描体积草酸钙结石生长相关的风险。
J Urol. 2021 Dec;206(6):1438-1444. doi: 10.1097/JU.0000000000001961. Epub 2021 Jul 21.

引用本文的文献

1
Metabolomics analysis reveals a protective effect of hydroxycitric acid on calcium oxalate-induced kidney injury.代谢组学分析揭示了羟基柠檬酸对草酸钙诱导的肾损伤的保护作用。
Iran J Basic Med Sci. 2024;27(10):1243-1250. doi: 10.22038/ijbms.2024.75089.16343.
2
Oxalate (dys)Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity.草酸盐(代谢)紊乱:人与人之间的差异、肾和代谢相关心脏毒性。
Genes (Basel). 2023 Aug 29;14(9):1719. doi: 10.3390/genes14091719.
3
Genetic manipulation of anti-nutritional factors in major crops for a sustainable diet in future.

本文引用的文献

1
Glyoxal formation and its role in endogenous oxalate synthesis.乙二醛的形成及其在内源性草酸盐合成中的作用。
Adv Urol. 2012;2012:819202. doi: 10.1155/2012/819202. Epub 2012 Apr 8.
2
Prophylaxis and therapeutic effects of raspberry (Rubus idaeus) on renal stone formation in Balb/c mice.覆盆子(悬钩子属)对 Balb/c 小鼠肾结石形成的预防和治疗作用。
Int Braz J Urol. 2011 Mar-Apr;37(2):259-66; discussion 267. doi: 10.1590/s1677-55382011000200013.
3
Renal lithiasis and nutrition.肾石病与营养
对主要作物中的抗营养因子进行基因操作以实现未来可持续饮食。
Front Plant Sci. 2023 Feb 15;13:1070398. doi: 10.3389/fpls.2022.1070398. eCollection 2022.
4
A metabolic readout of the urine metabolome of COVID-19 patients.新型冠状病毒肺炎患者尿液代谢组学的代谢分析。
Metabolomics. 2023 Jan 24;19(2):7. doi: 10.1007/s11306-023-01971-6.
5
Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs.非靶向代谢组学鉴定出一组用于诊断犬膀胱尿路上皮癌的尿液生物标志物,并与伴或不伴尿路感染的尿石症进行比较。
Metabolites. 2022 Feb 24;12(3):200. doi: 10.3390/metabo12030200.
Nutr J. 2006 Sep 6;5:23. doi: 10.1186/1475-2891-5-23.
4
Calcium stone disease: a multiform reality.钙结石病:一种多形态的实际情况。
Urol Res. 2005 Jun;33(3):194-8. doi: 10.1007/s00240-004-0459-x.
5
Epidemiology of nephrolithiasis today.当今肾结石的流行病学。
Urol Int. 2004;72 Suppl 1:1-5. doi: 10.1159/000076582.
6
Calcium oxalate aggregation in whole urine, new aspects of calcium stone formation and metaphylaxis.草酸钙在全尿中的聚集、钙结石形成与预防的新方面
Eur Urol. 2003 Apr;43(4):421-5. doi: 10.1016/s0302-2838(03)00058-7.
7
Epidemiology of nephrolithiasis.肾结石的流行病学
J Nephrol. 2000 Nov-Dec;13 Suppl 3:S45-50.
8
Solubility, inhibited growth and dissolution kinetics of calcium oxalate crystals in solutions, containing hippuric acid.草酸钙晶体在含有马尿酸的溶液中的溶解度、生长抑制及溶解动力学
Urol Res. 1993 May;21(3):181-5. doi: 10.1007/BF00590034.
9
Glycine loading and urinary oxalate excretion.甘氨酸负荷与尿草酸排泄
Urol Int. 1994;52(1):14-6. doi: 10.1159/000282562.
10
Oxalate metabolism and renal calculi.草酸盐代谢与肾结石
J Urol. 1982 Jan;127(1):148-51. doi: 10.1016/s0022-5347(17)53649-6.